BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
화요일, 9월 22

Palisade Bio Inc

PALINASDAQ
Trade with Public
Trade with Public
$1.69
0.16.29%
가까이에: Sep 18, 5:00 PM EST
$1.71
0.127.55%
프리마켓: 4:16 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Palisade Bio Financials

Palisade Bio (PALI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Palisade Bio Q2 EPS $(0.05), Inline, Sales $500.000K

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 91.38 percent increase over losses of $(0.58) per share from the same period last year. The
Benzinga Newsdesk

PRO
Palisade Bio Q1 EPS $(0.05) Misses $(0.04) Estimate

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 89.36 percent increase over losses of $(0.47) per share from the
Benzinga Newsdesk

Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December

Avi Kapoor

PRO
Palisade Bio Q3 EPS $(0.38) Misses $(0.27) Estimate

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.27) by 39.19 percent. This is a 83.62 percent increase over losses of $(2.32) per share from
Benzinga Newsdesk

PRO
Palisade Bio Q1 EPS $(0.47) Beats $(0.70) Estimate

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.70) by 32.86 percent. This is a 89.76 percent increase over losses of $(4.59) per share from the
Benzinga Newsdesk

Nasdaq Down 50 Points; US Initial Jobless Claims Rise

Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved